Literature DB >> 21473288

iASPP is important for bladder cancer cell proliferation.

Tao Liu1, Lin Li, WenFeng Yang, Hui Jia, MingKai Xu, JianBin Bi, ZeLiang Li, XianKui Liu, ZhenHua Li, HongWei Jing, ChuiZe Kong.   

Abstract

Inhibitor of apoptosis stimulatory protein phosphatase (iASPP) is a key inhibitor of p53 conserved from worm to human and is associated with cell proliferation and carcinogenesis in a variety of human cancers. Because iASPP is important for tumor cell apoptosis, it is a potential target for cancer gene therapy. However, it is still not clear whether iASPP is relevant to p53-deficient human bladder cancer. In the present study, iASPP was knocked down in bladder carcinoma 5637 and T24 cells (p53 defective) by lentiviral-mediated interfering short hairpin RNAs (siRNAs). MTT assay, BrdU incorporation assay, and colony formation assay were performed to investigate the role of iASPP on cell proliferation. It was suggested that iASPP knockdown led to cell growth deceleration and slow colony formation. A positive relationship between expression of iASPP and bladder cancer proliferation was found. The expression of iASPP may be critical for proliferation of bladder cancer cells. Our study indicates iASPP could be an important target for therapy in bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21473288     DOI: 10.3727/096504011x12935427587768

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  7 in total

1.  Increased expression of iASPP correlates with poor prognosis in FIGO IA2-IIA cervical adenocarcinoma following a curative resection.

Authors:  Fanming Kong; Xiaofeng Shi; Huzi Li; Pu Li; Jianchun Yu; XiaoJiang Li; Jun Chen; Yiyu Sun; Yingjie Jia
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.

Authors:  Zhengzheng Liu; Xin Zhang; Donghai Huang; Yong Liu; Xiaozhe Zhang; Lijun Liu; Guo Li; Yaozhang Dai; Haolei Tan; Jianyun Xiao; Yongquan Tian
Journal:  Med Oncol       Date:  2012-07-20       Impact factor: 3.064

3.  Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis.

Authors:  F Kong; Y Qi; H Liu; F Gao; P Yang; Y Li; Y Jia
Journal:  Clin Transl Oncol       Date:  2015-06-19       Impact factor: 3.405

4.  Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.

Authors:  Shaowei Qiu; Shuang Liu; Tengteng Yu; Jing Yu; Min Wang; Qing Rao; Haiyan Xing; Kejing Tang; Yinchang Mi; Jianxiang Wang
Journal:  BMC Cancer       Date:  2017-11-28       Impact factor: 4.430

5.  CDK1 interacts with iASPP to regulate colorectal cancer cell proliferation through p53 pathway.

Authors:  Wei Gan; Hua Zhao; Tiegang Li; Kuijie Liu; Jiangsheng Huang
Journal:  Oncotarget       Date:  2017-05-11

6.  MicroRNA-124 regulates the proliferation of colorectal cancer cells by targeting iASPP.

Authors:  Kuijie Liu; Hua Zhao; Hongliang Yao; Sanlin Lei; Zhendong Lei; Tiegang Li; Haizhi Qi
Journal:  Biomed Res Int       Date:  2013-04-10       Impact factor: 3.411

Review 7.  Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors.

Authors:  Peixin Dong; Kei Ihira; Junichi Hamada; Hidemichi Watari; Takahiro Yamada; Masayoshi Hosaka; Sharon J B Hanley; Masataka Kudo; Noriaki Sakuragi
Journal:  Oncotarget       Date:  2015-08-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.